Home / Journals / CJU / Vol.32, No.2, 2025
Special Issues
  • Open AccessOpen Access

    EDITORIAL

    What Makes a Good Surgeon? What I Learned Watching Hardy Hendren


    Canadian Journal of Urology, Vol.32, No.2, pp. 71-72, 2025, DOI:10.32604/cju.2025.066690 - 30 April 2025
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    Legends in Urology: Reflections on a Career in Academic Urology

    Peter T. Scardino
    Canadian Journal of Urology, Vol.32, No.2, pp. 73-80, 2025, DOI:10.32604/cju.2025.064714 - 30 April 2025
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Emergency room management of urolithiasis: a sex-based comparison

    Mark Shilling1, Lauren S. Faber2, Hoi Doan2, Merry Peckham2, Timothy R. Petersen1,3, Reza Ehsanian1, Frances Alba2,*
    Canadian Journal of Urology, Vol.32, No.2, pp. 81-88, 2025, DOI:10.32604/cju.2025.063415 - 30 April 2025
    Abstract Introduction: Existing literature has highlighted disparities in acute pain management across racial and sex groups in both emergency department and pre-hospital settings. This study aimed to evaluate prescribing patterns among physicians and advanced practice providers for patients with upper tract urolithiasis in an academic emergency department. Materials and Methods: Retrospective chart review of patients diagnosed with upper tract urolithiasis was performed to evaluate age, sex, race, ethnicity, stone size and location, presence of hydronephrosis, admission status, history of prior nephrolithiasis, medications administered in the emergency department (ED), requests for urology consult or referral, and discharge medications. More >

  • Open AccessOpen Access

    ARTICLE

    The cost and guideline adherence of direct-to-consumer telemedicine companies offering gender-affirming hormone therapy

    Nicholas Sellke1,2,*, Erin Jesse1,2, Justin M. Dubin3, Tomislav D. Medved1,2, Neha S. Basti4, Janvi Ramchandra2, Robert E. Brannigan4, Joshua A. Halpern4, Nannan Thirumavalavan1,2
    Canadian Journal of Urology, Vol.32, No.2, pp. 89-94, 2025, DOI:10.32604/cju.2025.065004 - 30 April 2025
    Abstract Introduction: Direct-to-consumer (DTC) telemedicine has emerged as an option for transgender patients seeking gender affirming hormone therapy (GAHT). We aimed to characterize the healthcare services provided by DTC telemedicine companies offering GAHT and to compare their costs to a tertiary care center. Methods: We identified DTC telemedicine platforms offering GAHT via internet searches and extracted information from their websites related to evaluation, treatment, monitoring, and cost. Cost of the DTC GAHT was compared to cost for comparable services at a tertiary care center. Results: Six DTC companies were identified. All platforms utilized an informed consent model… More >

  • Open AccessOpen Access

    ARTICLE

    The intersection of histologies: navigating the complexity of a renal collision tumor

    Tatiana Henriksson1,*, Katharina Mitchell2, Reima El Naili3, Ali Hajiran2
    Canadian Journal of Urology, Vol.32, No.2, pp. 95-99, 2025, DOI:10.32604/cju.2025.065002 - 30 April 2025
    Abstract Renal cell carcinoma is a heterogeneous group of renal tumors characterized by several histological subtypes. Herein, we discuss an unusual case of a 55-year-old male who presented as a consultation to our urology clinic with an incidentally found renal mass. After shared decision making patient proceeded with a Robotic Assisted Laparoscopy (RAL) left sided partial nephrectomy. Final pathology confirmed the presence of high nuclear grade mixed clear cell and papillary renal cell carcinoma (RCC) of the left kidney (pT3aN0M0). This case elucidates a very rare incidence of a patient seen to have a collision tumor, More >

  • Open AccessOpen Access

    ARTICLE

    Differences at diagnosis between long-term survivors and not long-term survivors in metastatic renal cell carcinoma initially treated with TKI

    Miguel Ángel Gómez-Luque*, Guillermo Lendínez-Cano, Carmen Belén Congregado-Ruiz, Ignacio Osman-García, Rafael Antonio Medina-López
    Canadian Journal of Urology, Vol.32, No.2, pp. 101-109, 2025, DOI:10.32604/cju.2025.063073 - 30 April 2025
    Abstract Introduction: In recent years, significant advancements in the treatment of metastatic renal cell carcinoma (mRCC) have notably extended overall survival (OS) times, particularly with the introduction of tyrosine kinase inhibitors (TKIs) and combination immunotherapy. However, survival outcomes in mRCC remain highly variable. Materials and Methods: This study retrospectively analyzed clinical and demographic factors at diagnosis in patients treated for mRCC to identify predictors of long-term survival (defined as OS ≥ 48 months). Patients were categorized into long-term survivors (LTS) and non-long-term survivors (nLTS). Results: The analysis revealed that factors such as better Karnofsky Performance Status (KPS), More >

  • Open AccessOpen Access

    ARTICLE

    Comparison of clinical effectiveness and safety of 272 µm and 365 µm holmium lasers in retrograde intrarenal surgery

    Demirhan Örsan Demir1,*, Yusuf Gökkurt1, Salih Bürlükkara2, Turgay Kaçan1, Ali Kaan Yıldız1, Ufuk Bozkurt2, Tolga Karakan1
    Canadian Journal of Urology, Vol.32, No.2, pp. 111-118, 2025, DOI:10.32604/cju.2025.063970 - 30 April 2025
    Abstract Introduction: Surgeons typically prefer 270 µm and 272 µm laser probes in retrograde intrarenal surgery (RIRS) due to the reduced deflection capacity of flexible ureterorenoscopes when using larger probe diameters. This study aims to investigate the effects of 272 and 365 µm holmium laser probes on operative time, clinical efficacy, and complication rates in RIRS. Materials and Methods: A total of 285 patients with proximal ureteral or kidney stones who met the inclusion criteria were enrolled in the study. Patients were divided into two groups based on laser probe thickness: 272 µm and 365 µm. Stone-free… More >

  • Open AccessOpen Access

    ARTICLE

    Comparing functional outcomes of glansectomy with or without glans reconstruction

    Mihály Murányi1,*, András Domoszlai1, Attila Csaba Nagy2, Tibor Flaskó1
    Canadian Journal of Urology, Vol.32, No.2, pp. 119-127, 2025, DOI:10.32604/cju.2025.063821 - 30 April 2025
    Abstract Introduction: We aimed to compare the oncological and functional outcomes of glansectomy and split-thickness skin graft reconstruction (GR) with those of glansectomy alone (GA) and penile amputation (PA). Materials and Methods: This retrospective study included patients with penile carcinoma or penile intraepithelial neoplasia diagnosed between 2017 and 2022. Surgical outcomes, complications, and oncological outcomes were assessed through a chart review, and functional outcomes were assessed using a questionnaire administered to patients who underwent GR (group A), GA (group B), or PA (group C). Results: Six, eight, and seven patients were enrolled in groups A, B, and… More >

Per Page:

Share Link